Peter Clark, MD
Retina Specialist · Wenatchee, WANPI 1548616485
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,914 of the $7,259 with a category attached, or 81.5%. Carl Zeiss Meditec Digital Innovations LLC accounts for 81.5% of it on its own, with 10 other manufacturers making up the rest. 2024 is the largest year on record at $5,914, more than ten times the $401 reported in 2019.
Across 20 payments — averaging $362.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec Digital Innovations LLC$6K
- Regeneron Healthcare Solutions, Inc.$375
- Glaukos Corporation$181
- Alcon$172
- Alimera Sciences, Inc.$148
- Genentech USA, Inc.$136
- plus $333 from 5 others
What the payments were for
- Food & beverage$1,34519%
- Other$5,91481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | 1 | $5,914 |
| Regeneron Healthcare Solutions, Inc. | 6 | $375 |
| Glaukos Corporation | 2 | $181 |
| Alcon | 2 | $172 |
| Alimera Sciences, Inc. | 3 | $148 |
| Genentech USA, Inc. | 1 | $136 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $116 |
| Ivantis, Inc | 1 | $107 |
| Novartis | 1 | $72 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$5,914
- EYLEA$364
- iStent inject W$162
- Centurion$147
- SUSVIMO$136
- Iluvien$125
- Tecnis IOL$116
- CATALYS SYSTEM$116
- Hydrus$107
How this compares
Too few retina specialist providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 36 | $1,238 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 72 | $1,042 |
| Rifampin | 13 | $752 |
| Brimonidine Tartrate | 19 | $571 |
| Ketorolac Tromethamine | 24 | $402 |
| Latanoprost | 36 | $373 |
| Timolol Maleate | 16 | $147 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Wenatchee
- George KoRenton$28K
- Evelyn FuPuyallup$22K
- Rahul MandigaAuburn$17K
- Himanshu BandaTacoma$15K
- Minh TrinhAuburn$4K
- Michael GilbertBellevue$3K
- Benjamin ReissAuburn$2K
- David DruckerSeattle$1K
- Brenda Myers PowellFederal Way$422
- Kinza AhmadEverett$363
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.